Psoriasis: open trials in Australia

8 open trials have a site in Australia. Registry data; only the trial team decides who can take part.

NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
The Kids Research Institute Australia on behalf of the Centre for Child Health Research, Nedlands · Mater Hospital Brisbane Inflammatory Bowel Diseases, South Brisbane · The Children's Hospital at Westmead, Westmead
Registry updated 2026-11-03
NCT07736586
A Study of HL40626S Tablets in Healthy Adults
Trial Treatment · Phase 1 · HighsLab Therapeutics Inc.
Nucleus Network, Melbourne · Nucleus Network Pty Ltd, Melbourne
Registry updated 2026-10-29
NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Skin Health Institute Inc., Carlton · Monash Medical Centre Clayton, Clayton · The Skin Hospital, Darlinghurst · Dr Rodney Sinclair Pty Ltd., East Melbourne · Veracity Clinical Research, Greenslopes · St George Dermatology & Skin Cancer Centre, Kogarah · Westmead Hospital, Westmead · Woolloongabba
Registry updated 2026-10-28
NCT07850310
A Clinical Trial of MK-8644 in Healthy Participants and Participants With Psoriasis (MK-8644-001)
Trial Treatment · Phase 1 · Merck Sharp & Dohme LLC
Nucleus Network ( Site 0001), Melbourne
Registry updated 2026-10-27
NCT04772079
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Queensland Children's Hospital, Brisbane · Monash Health, Clayton · Darlinghurst · Melbourne · Westmead · Woolloongabba
Registry updated 2026-10-26
NCT07286058
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Trial Treatment · Phase 3 · Takeda
R.K. Will Pty Ltd, Victoria Park
Registry updated 2026-09-09
NCT06100744
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Trial Treatment · Phase 3 · AbbVie
Monash Health - Monash Medical Centre - Clayton /ID# 260255, Clayton
Registry updated 2026-09-01
NCT07455578
Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
Trial Treatment · Phase 1 · Seismic Therapeutic AU Pty Ltd
University of the Sunshine Coast Clinical Trials, Birtinya, Birtinya · Novatrials, Charlestown
Registry updated 2026-06-01

All Psoriasis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error